share_log

Investors in Shanghai Kinlita Chemical (SZSE:300225) From Three Years Ago Are Still Down 72%, Even After 21% Gain This Past Week

Investors in Shanghai Kinlita Chemical (SZSE:300225) From Three Years Ago Are Still Down 72%, Even After 21% Gain This Past Week

儘管上週上漲了21%,但三年前上海金力泰化學(深圳證券交易所代碼:300225)的投資者仍下跌了72%
Simply Wall St ·  02/24 19:40

It's nice to see the Shanghai Kinlita Chemical Co., Ltd. (SZSE:300225) share price up 21% in a week. But that doesn't change the fact that the returns over the last three years have been stomach churning. The share price has sunk like a leaky ship, down 72% in that time. So it sure is nice to see a bit of an improvement. The thing to think about is whether the business has really turned around.

很高興看到上海金立泰化工有限公司(深圳證券交易所代碼:300225)的股價在一週內上漲了21%。但這並不能改變過去三年的回報令人大跌眼鏡的事實。股價像一艘漏水的船一樣下跌,當時下跌了72%。因此,看到一點改進肯定是件好事。要考慮的是業務是否真的發生了轉機。

Although the past week has been more reassuring for shareholders, they're still in the red over the last three years, so let's see if the underlying business has been responsible for the decline.

儘管過去一週令股東更加放心,但在過去三年中,他們仍處於虧損狀態,所以讓我們看看基礎業務是否是造成下降的原因。

Shanghai Kinlita Chemical isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

上海金立達化工目前尚未盈利,因此大多數分析師會着眼於收入的增長,以了解基礎業務的增長速度。一般而言,沒有利潤的公司預計每年收入將增長,而且速度很快。那是因爲如果收入增長可以忽略不計,而且從來沒有盈利,就很難確信一家公司能否實現可持續發展。

Over the last three years, Shanghai Kinlita Chemical's revenue dropped 15% per year. That means its revenue trend is very weak compared to other loss making companies. And as you might expect the share price has been weak too, dropping at a rate of 20% per year. We prefer leave it to clowns to try to catch falling knives, like this stock. There is a good reason that investors often describe buying a sharply falling stock price as 'trying to catch a falling knife'. Think about it.

在過去的三年中,上海金力泰化工的收入每年下降15%。這意味着與其他虧損公司相比,其收入趨勢非常疲軟。正如你所預料的那樣,股價也一直疲軟,每年下跌20%。我們更願意讓小丑去抓掉落的刀具,比如這隻股票。投資者經常將買入大幅下跌的股價描述爲 “試圖抓住一把下跌的刀”,這是有充分理由的。想一想。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以在下面看到收入和收入如何隨着時間的推移而變化(點擊圖片了解確切的值)。

earnings-and-revenue-growth
SZSE:300225 Earnings and Revenue Growth February 25th 2024
SZSE: 300225 2024 年 2 月 25 日收益和收入增長

This free interactive report on Shanghai Kinlita Chemical's balance sheet strength is a great place to start, if you want to investigate the stock further.

如果你想進一步調查該股,這份關於上海金立泰化學資產負債表實力的免費互動報告是一個不錯的起點。

A Different Perspective

不同的視角

We're pleased to report that Shanghai Kinlita Chemical shareholders have received a total shareholder return of 6.9% over one year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 1.0% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. It's always interesting to track share price performance over the longer term. But to understand Shanghai Kinlita Chemical better, we need to consider many other factors. Even so, be aware that Shanghai Kinlita Chemical is showing 2 warning signs in our investment analysis , you should know about...

我們很高興地向大家報告,上海金力泰化工的股東在一年內獲得了 6.9% 的總股東回報率。由於一年期股東總回報率好於五年期股東總回報率(後者爲每年1.0%),因此該股的表現似乎在最近有所改善。在最好的情況下,這可能暗示着一些真正的業務勢頭,這意味着現在可能是深入研究的好時機。長期跟蹤股價表現總是很有意思的。但是,爲了更好地了解上海金立化學,我們需要考慮許多其他因素。即便如此,請注意,上海金立達化工在我們的投資分析中顯示出兩個警告信號,您應該知道...

We will like Shanghai Kinlita Chemical better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些大規模的內幕收購,我們會更喜歡上海金立達化學。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論